Bone Biologics Stock Forward View - Accumulation Distribution
| BBLG Stock | USD 1.63 0.01 0.61% |
Bone Stock outlook is based on your current time horizon. We suggest always using this module together with an analysis of Bone Biologics' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 3rd of February 2026, the relative strength index (RSI) of Bone Biologics' share price is approaching 44 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Bone Biologics, making its price go up or down. Momentum 44
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (1.14) | EPS Estimate Current Year (2.36) | EPS Estimate Next Year (1.36) | Wall Street Target Price 22.25 | EPS Estimate Current Quarter (1.23) |
Using Bone Biologics hype-based prediction, you can estimate the value of Bone Biologics Corp from the perspective of Bone Biologics response to recently generated media hype and the effects of current headlines on its competitors.
Bone Biologics after-hype prediction price | USD 1.63 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Bone Biologics to cross-verify your projections. Bone Biologics Additional Predictive Modules
Most predictive techniques to examine Bone price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bone using various technical indicators. When you analyze Bone charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 640.72 | 1542.4 |
| Check Bone Biologics Volatility | Backtest Bone Biologics | Information Ratio |
Bone Biologics Trading Date Momentum
| On February 02 2026 Bone Biologics Corp was traded for 1.63 at the closing time. The top price for the day was 1.70 and the lowest listed price was 1.62 . The trading volume for the day was 32.8 K. The trading history from February 2, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.61% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Bone Biologics to competition |
Other Forecasting Options for Bone Biologics
For every potential investor in Bone, whether a beginner or expert, Bone Biologics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bone Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bone. Basic forecasting techniques help filter out the noise by identifying Bone Biologics' price trends.Bone Biologics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bone Biologics stock to make a market-neutral strategy. Peer analysis of Bone Biologics could also be used in its relative valuation, which is a method of valuing Bone Biologics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bone Biologics Market Strength Events
Market strength indicators help investors to evaluate how Bone Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bone Biologics shares will generate the highest return on investment. By undertsting and applying Bone Biologics stock market strength indicators, traders can identify Bone Biologics Corp entry and exit signals to maximize returns.
Bone Biologics Risk Indicators
The analysis of Bone Biologics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bone Biologics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bone stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.29 | |||
| Standard Deviation | 4.52 | |||
| Variance | 20.44 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Bone Biologics
The number of cover stories for Bone Biologics depends on current market conditions and Bone Biologics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bone Biologics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bone Biologics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Bone Biologics Short Properties
Bone Biologics' future price predictability will typically decrease when Bone Biologics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bone Biologics Corp often depends not only on the future outlook of the potential Bone Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bone Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.5 M | |
| Cash And Short Term Investments | 3.3 M |
Check out Historical Fundamental Analysis of Bone Biologics to cross-verify your projections. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Bone have expansion opportunities? Factors like these will boost the valuation of Bone Biologics. Projected growth potential of Bone fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Bone Biologics demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
The market value of Bone Biologics Corp is measured differently than its book value, which is the value of Bone that is recorded on the company's balance sheet. Investors also form their own opinion of Bone Biologics' value that differs from its market value or its book value, called intrinsic value, which is Bone Biologics' true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because Bone Biologics' market value can be influenced by many factors that don't directly affect Bone Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Bone Biologics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bone Biologics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Bone Biologics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.